1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2025-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Department of Health and Human Services National Institutes of Health Document Type:Grants Notice Funding Opportunity Number:PA-24-245 Funding Opportunity Title:PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Grant Category of Funding Activity:Education Income Security and Social Services Expected Number of Awards: Assistance Listings:93.
113 -- Environmental Health 93. 121 -- Oral Diseases and Disorders Research 93. 142 -- NIEHS Hazardous Waste Worker Health and Safety Training 93.
143 -- NIEHS Superfund Hazardous Substances_Basic Research and Education 93. 172 -- Human Genome Research 93. 173 -- Research Related to Deafness and Communication Disorders 93.
213 -- Research and Training in Complementary and Integrative Health 93. 233 -- National Center on Sleep Disorders Research 93. 242 -- Mental Health Research Grants 93.
273 -- Alcohol Research Programs 93. 279 -- Drug Abuse and Addiction Research Programs 93. 286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health 93.
307 -- Minority Health and Health Disparities Research 93. 350 -- National Center for Advancing Translational Sciences 93. 351 -- Research Infrastructure Programs 93.
361 -- Nursing Research 93. 393 -- Cancer Cause and Prevention Research 93. 394 -- Cancer Detection and Diagnosis Research 93.
395 -- Cancer Treatment Research 93. 837 -- Cardiovascular Diseases Research 93. 838 -- Lung Diseases Research 93.
839 -- Blood Diseases and Resources Research 93. 840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders 93. 846 -- Arthritis, Musculoskeletal and Skin Diseases Research 93.
847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research 93. 853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders 93. 855 -- Allergy and Infectious Diseases Research 93.
859 -- Biomedical Research and Research Training 93. 865 -- Child Health and Human Development Extramural Research 93. 867 -- Vision Research 93.
879 -- Medical Library Assistance Cost Sharing or Matching Requirement:No Last Updated Date:Apr 01, 2025 Original Closing Date for Applications:Apr 05, 2025 Current Closing Date for Applications:Sep 05, 2025 Archive Date:Oct 05, 2025 Estimated Total Program Funding: Eligible Applicants:Small businesses Additional Information on Eligibility:Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
## Additional Information Agency Name:National Institutes of Health Description:This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications.
United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).
This Parent Funding Opportunity Announcement does not accept clinical trials. Link to Additional Information:https://grants. nih.
gov/grants/guide/pa-files/PA-24-245. html Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
#### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes. To continue working, click on the "OK" button below. This is being done to protect your privacy.
Unsaved changes will be lost.
According to the current listing, eligibility includes: U. S. small business concerns eligible for SBIR with majority U. S. ownership. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: up to $645,062; Phase II: up to $1,940,509. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 5, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
PHS 2025-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is funded by National Institutes of Health. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article